CoChat

Insulin detemir compared with NPH insulin in children and adolescents with Type 1 diabetes

Open access
Robertson, K. J., Schoenle, E., Gucev, Z., Mordhorst, L., Gall, M.‐A., Ludvigsson, J. · 2007 · Diabetic Medicine
Cited by 149

The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.

Abstract

Aims This study compared the effect of insulin detemir on glycaemic control (HbA 1c, fasting plasma glucose and variability thereof) with that of Neutral Protamine Hagedorn human isophane (NPH) insulin, both combined with insulin aspart, in children with Type 1 diabetes mellitus, and compared the safety of these treatments. Methods In this 26‐week, open‐label, randomized (2 : 1), parallel‐group study, 347 (140 prepubertal and 207 pubertal) children with Type 1 diabetes, aged 6–17 years, received insulin detemir (n = 232) or NPH insulin (n = 115) once or twice daily, according to the prestudy regimen, plus premeal insulin aspart. Results The mean HbA 1c decreased by ∼0.8% with both treatments. After 26 weeks, the mean difference in HbA 1c was 0.1% (95% confidence interval −0.1, 0.3) (insulin detemir 8.0%, NPH insulin 7.9%). Within‐subject variation in self‐measured fasting plasma glucose was significantly lower with insulin detemir than with NPH insulin (SD 3.3 vs. 4.3, P < 0.001), as was mean fasting plasma glucose (8.4 vs. 9.6 mmol/l, P = 0.022). The risk of nocturnal hypoglycaemia (22.00–07.00 h) was 26% lower with insulin detemir (P = 0.041) and the risk of 24‐h hypoglycaemia was similar with the two treatments (P = 0.351). The mean body mass index (BMI) Z‐score was lower with insulin detemir (P < 0.001). Conclusions Basal‐bolus treatment with insulin detemir or NPH insulin and premeal insulin aspart in children and adolescents with Type 1 diabetes mellitus improved HbA 1c to a similar degree. The lower and more predictable fasting plasma glucose, lower risk of nocturnal hypoglycaemia and lower BMI observed with insulin detemir are clinically significant advantages compared with NPH insulin.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1464-5491.2007.02024.x

Cites

13 of 13 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 13 references

Cited by

See all 149

Metadata

Authors
Robertson, K. J., Schoenle, E., Gucev, Z., Mordhorst, L., Gall, M. ‐., & Ludvigsson, J.
Venue
Diabetic Medicine
Publisher
Wiley
Published
2007-01
Volume
24
Issue
1
Pages
27-34
ISSN
  • 0742-3071 (ISSN-L)
  • 1464-5491
OpenAlex
W2029491585
Cited by
149
References
13
FWCI
13.31
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Insulin detemir compared with NPH insulin in children and adolescents with Type 1 diabetes. https://app.cochat.ai/papers/10.1111/j.1464-5491.2007.02024.x
The paper
Robertson, K. J., Schoenle, E., Gucev, Z., Mordhorst, L., Gall, M. ‐., & Ludvigsson, J. (2007). Insulin detemir compared with NPH insulin in children and adolescents with Type 1 diabetes. Diabetic Medicine. https://doi.org/10.1111/j.1464-5491.2007.02024.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.